Congress ticker disclosure profile

As of July 18 at 9:23 AM EDT

Public STOCK Act rows mentioning

IMBBY

A factual page for public Congressional disclosures that reference IMBBY. Veridion shows filed rows, disclosed amount ranges, dates, and source links. It does not imply motive or wrongdoing.

90d rows

0

Feed lifetime

13

Member filers

4

Disclosed ranges

$40K

Latest source-stamped receipts

Latest trade Jul 10, 2023

DateMemberActionAmountFiledReceipt
Jul 10, 2023Daniel GoldmanSell$1,001 to $15,000Aug 13, 2023Open card
Nov 13, 2020Greg GianforteBuyReceipt pending ingestionDec 2, 2020Receipt pending ingestion
Apr 15, 2020John RutherfordSellReceipt pending ingestionDate not disclosedReceipt pending ingestion
Apr 15, 2020John RutherfordSell$1,001 to $15,000May 1, 2020Open card
Mar 18, 2020Greg GianforteBuyReceipt pending ingestionApr 7, 2020Receipt pending ingestion
May 28, 2019Mikie SherrillSellReceipt pending ingestionDate not disclosedReceipt pending ingestion
May 28, 2019Mikie SherrillSell$1,001 to $15,000Date not disclosedOpen card
Dec 21, 2018Greg GianforteSellReceipt pending ingestionJan 23, 2019Receipt pending ingestion
May 1, 2018John RutherfordBuyReceipt pending ingestionAug 20, 2018Receipt pending ingestion
May 1, 2018John RutherfordBuy$1,001 to $15,000Date not disclosedOpen card
Mar 26, 2018Greg GianforteBuyReceipt pending ingestionApr 13, 2018Receipt pending ingestion
Jul 11, 2017John RutherfordBuyReceipt pending ingestionAug 20, 2018Receipt pending ingestion
Jul 11, 2017John RutherfordBuy$1,001 to $15,000Date not disclosedOpen card

Source creed

This page is assembled from public STOCK Act disclosure records in the Veridion warehouse. 5 of 13 filed rows include disclosed amount ranges (38%). Rows without ranges stay labeled. Identification only; it does not imply motive or wrongdoing.

Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.